Recurrent or Metastatic Head and Neck Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent or Metastatic Head and Neck Carcinoma
| Record | Firm | Date |
|---|---|---|
| Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT07686588) | Biying Chen | 2026-07-01 |
| Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer (NCT02347332) | Pierre Fabre Medicament | 2014-04-25 |
Track Recurrent or Metastatic Head and Neck Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.